Candel Therapeutics, Inc. (CADL)

Last Closing Price: 5.26 (2025-12-04)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Candel Therapeutics, Inc. (CADL) Cost of Goods Sold data is not available.

Figures for fiscal quarter ending 2025-09-30
Income Statement Financials
--
$-11.27M
Cost of Goods Sold
--
--
$13.21M
$-13.21M
$1.94M
$-11.27M
$-11.27M
$-11.27M
$-11.27M
$-11.27M
$-11.27M
$-13.21M
$-13.01M
54.89M
54.89M
$-0.21
$-0.21
Balance Sheet Financials
$90.13M
$1.36M
$3.46M
$93.60M
$10.93M
$0.97M
$2.54M
$13.47M
$80.12M
$80.12M
$80.12M
54.90M
Cash Flow Statement Financials
$-27.74M
$-0.15M
$12.20M
$102.92M
$87.23M
$-15.69M
$2.53M
--
--
Fundamental Metrics & Ratios
8.25
--
--
0.01
0.06
--
--
--
--
--
--
$-27.89M
--
--
--
--
--
--
--
-14.06%
-14.06%
-12.04%
-13.90%
$1.46
$-0.51
$-0.51